NCT00114829|UnknownPhase 4
Loading search results
Sponsor study identifier
Secondary identifiers
interventional
60
1 country
1
Study Start
July 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe purpose of this study is to determine whether a colonic tumor can be classified as malignant or benign with magnetic resonance (MR) colonography. Patients with a verified colon carcinoma or benign tumor based on diverticulitis are offered a MR colonography with intravenous (I.V.) contrast. The tumor is classified as malignant or benign by assessing the dynamic contrast uptake and morphology. The Investigator is blinded from the verified diagnosis and the MR classification is compared to the histological diagnosis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 17, 2005
Actual (reported)June 20, 2005
Actual (reported)July 2005
Date type not reportedThis date has not been verified as actual or estimated.
Sensitivity in determining malignant or benign diagnose
Sensitivity/specificity of MR colonography
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Department of Radiology Copenhagen University Hospital Herlev
Herlev, Dk-.2730, Denmark
Achiam MP, Andersen LP, Klein M, Logager V, Chabanova E, Thomsen HS, Rosenberg J. Differentiation between benign and malignant colon tumors using fast dynamic gadolinium-enhanced MR colonography; a feasibility study. Eur J Radiol. 2010 Jun;74(3):e45-50. doi: 10.1016/j.ejrad.2009.03.033. Epub 2009 May 5.
Michael P Achiam, M.D.
Department of Radiology Copenhagen University Hospital Herlev
First Submitted
June 17, 2005
First Posted
June 20, 2005
Study Start
July 2005
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
March 9, 2006
Record last verified: 2005-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum
Contact the study team to confirm eligibility.